Article
On-target mutations confer resistance to WRN helicase inhibitors in Microsatellite Unstable Cancer Cells
2025-12-27
Abstract excerpt
Werner helicase inhibitors (WRNi) are in clinical development for microsatellite-unstable (MSI) tumors with defective DNA mismatch repair. Here, we investigate how cancer cell evolution shapes response to WRN inhibition and informs potential resistance mechanisms. Genome-wide CRISPR screens combined with WRN knockout did not identify bypass mechanisms, underscoring WRN’s essential, non-redundant function in MSI ce...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- fc74df24-25bf-57a6-9d95-2865f45a5757
- DOI
- 10.64898/2025.12.23.695783
